220114-01-2COc1ccc(C(N)(c2ccc(OC)cc2)[C@@H](N)C(C)C)cc1.Cc1cc(C)cc(P(c2cc(C)cc(C)c2)c2ccc3ccccc3c2-c2c(P(c3cc(C)cc(C)c3)c3cc(C)cc(C)c3)ccc3ccccc23)c1.[Cl][Ru][Cl]UTQCNMRDWASSEC-OGLOXHGMSA-L안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H315 (97.6%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
용도Catalyst for:Preparation of cyclometalated ruthenium 1,1-dianisyl-2-isopropyl-1,2-ethylenediamine complexes via asymmetric hydrogenation of ketonesEnantioselective hydrogenation of an α-alkoxy substituted ketone with chiral ruthenium (phosphinoferrocenyl)oxazoline complexesNonclassical asymmeteric hydrogen transfer between alcohols and carbonyl compoundsAsymmetric hydrogenation of amino and heteroaromatic ketonesPharmacologically active substituted oxazolidinone used as NPC1L1 ligand for inhibition of cholesterol absorption
220114-01-2